1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 11 MAY 2015

Cancer Drug News 11 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Diversification To Bolster Celgene's Revenues
Industry Brief - Roche's Venetoclax Gains FDA Breakthrough Therapy Designation
Industry Trend Analysis - Zykadia Will Not Surpass Xalkori Without First-Line Approval
Industry Brief - ESSA's IND Application For EPI-506 Placed On Clinical Hold By FDA
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Gastric Cancers
Industry Brief - Baxter Seeks EU Approval For MM-398 In Post-Gemcitabine MPC
Industry Brief - Can-Fite's CF102 Phase II HCC Trial Approved In Europe
Industry Trend Analysis - CytRx' Outperformance To Continue
Industry Brief - Plexxikon/Merck Collaborate On PLX3397/Keytruda Combination Trial
Industry Brief - COT Granted European Patent Covering COTI-2
Industry Brief - Qu Biologics Granted EU Patent Covering Use Of Bacterial Compositions In Cancer
Industry Brief - Acacia Reports Positive Results From Phase II Study With APD403 In CINV
Industry Brief - FDA Grants Fast Track Designation To Sucampo's Cobiprostone
Industry Trend Analysis - EpiTherapeutics Acquisition Will Be Start Of Oncology Deals For Gilead In 2015

Table Of Contents

Cancer Drug News 11 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.